MedDataX Logo

The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease

NCT ID: NCT04874753

Last Updated: 2021-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-03

Study Completion Date

2021-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

COVID-19 pandemic affected the admission of patients to the hospital especially the older patients (\> 65 years old) because of curfews and the reluctance of patients to apply to the hospitals. Chronic kidney disease is characterized with the progressive loss of kidney function over the time and regular follow-up of patients for their kidney function and treatment of complications is recommended in these patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Kidney Injury in Patients With CoVID-19

NCT04872764

Covid19 Acute Kidney Injury
COMPLETED

Physical Activity Level in Patients with Chronic Kidney Disease During COVID-19 Pandemic

NCT04745923

Covid19 Chronic Kidney Diseases
COMPLETED

COVID-19 RELATED KIDNEY DAMAGE

NCT04706325

Acute Kidney Injury
UNKNOWN

Acute Kidney Injury Risk in COVID-19

NCT04874779

Sever Acute Respiratory Syndrome and Acute Kidney Injury Acute Kidney Injury
COMPLETED

The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU

NCT04799600

COVID19 Acute Renal Failure
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The chronis kidney disease patients followed in Nephrology outpatient unit are going to be enrolled in the study and their kidney functions (calculated with the mdrd formula to asses the estimated glomerular filtration rate (eGFR)) will be evaluated 6 months before and after the COVID-19 pandemia. And the rate of initiation of renal replacement therapies and the change in proteinuria will be evaluated 6 months before and after the COVID-19 pandemic.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Chronic Kidney Diseases Proteinuria

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

change in kidney function and proteinuria

change in eGFR nad proteinuria in patients with chronic kidney disease

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with chronic kidney disease on regular follow-up for 6 months before the COVID19 pandemic.

Exclusion Criteria

* patients without chronic kidney disease
* patients not on routine follow-up for 6 months before the COVID19 pandemic
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uşak University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zelal Adibelli

Assistant Prof. Zelal Adibelli

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zelal Adıbelli

Role: PRINCIPAL_INVESTIGATOR

Uşak University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Usak University

Uşak, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UsakU4

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immune Response Following COVID-19 in Hemodialysis Patients
NCT05307601 COMPLETED
Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
NCT04491227 UNKNOWN
Acute Kidney Injury in Critical COVID-19: Outcomes and Risks
NCT07089693 COMPLETED
Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units
NCT04459975 UNKNOWN
Incidence of Acute Kidney Injury in Covid-19
NCT05467956 COMPLETED
Acute Kidney Injury and Acute Kidney Disease in COVID-19
NCT04353583 COMPLETED
Patients With Acute Renal Failure During Severe COVID-19
NCT05077163 UNKNOWN
Acute Kidney Injury in Patients Hospitalized With COVID-19
NCT04316299 COMPLETED
Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study
NCT04815850 COMPLETED
Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
NCT00307463 COMPLETED PHASE4
Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients
NCT06674031 RECRUITING
Incidence and Outcomes of Acute Kidney Injury in Trauma Patients Admitted to Critical Care
NCT05381493 COMPLETED
Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis
NCT06104046 UNKNOWN
Kidney Disease After COVID-19
NCT05328986 COMPLETED
Acute Kidney Injury Among COVID-19 Positive Patients
NCT04979195 COMPLETED
Chronic Kidney Disease Among Hypertensive Patients in Ha'il, Saudi Arabia
NCT05030480 COMPLETED
Sarcopenia and Physical Performance in Hemodialysis Patients
NCT04669184 UNKNOWN
Acute Kidney Dysfunction in COVID-19 and Non-COVID-19 Related ARDS
NCT05699889 COMPLETED
Role of Prohepcidin in Uremic Patients
NCT01735773 COMPLETED
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
NCT06363097 RECRUITING
Kidney in Coronavirus Disease 2019 Registry
NCT04797091 COMPLETED
The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19
NCT04932876 UNKNOWN
Early Renal Replacement Therapy in COVID 19 Patients With AKI Does it Improve the Outcome?
NCT05274685 COMPLETED NA
Acute KIDnEy Injury in CoviD-19
NCT04583293 COMPLETED
Development, Feasibility Testing and Validation of a Survey Set to Measure Patient-Reported Outcomes Among Hemodialysis Patients in Turkey
NCT05441020 COMPLETED